PRESTIZIA
Prestizia acquired an exclusive worldwide license on a patent for a method of characterizing HIV cell tropism. Prestizia’s technology is based on the identification of microRNA signatures[1]. This technology could pave the way for a large number of clinical applications, including the possibility of identifying patients eligible to a treatment for viral diseases including HIV or differentiating types of cancerous tumors.
PRESTIZIA
Industry:
Biotechnology
Founded:
2011-01-01
Address:
Paris, Ile-de-France, France
Country:
France
Website Url:
http://www.prestizia.fr
Status:
Active
Similar Organizations
Elegen
Elegen is a biotechnology company that develops microfluidic technology.
Molbiotech
Molbiotech is a biotechnology company that develops bioproducts.
More informations about "Prestizia"
Prestizia - Crunchbase Company Profile & Funding
Prestizia acquired an exclusive worldwide license on a patent for a method of characterizing HIV cell tropism. Prestizia’s technology is based on the identification of microRNA signatures[1]. …See details»
PRESTIZIA - Societe.com
Dec 26, 2019 PRESTIZIA, société par actions simplifiée, au capital social de 657692,00 EURO, dont le siège social est situé au 14 RUE AMBROISE CROIZAT, 77183 CROISSY …See details»
Prestizia Company Profile 2024: Valuation, Investors, Acquisition ...
Prestizia General Information Description. Provider of biotechnology research and development services. The company engages in developing novel diagnostic assays for viral infections and …See details»
Prestizia SASU - Drug pipelines, Patents, Clinical trials - Synapse
Explore Prestizia SASU with its drug pipeline, therapeutic area, technology platform, 1 news.See details»
Prestizia - National Company | Open Datasets
Company Name: Prestizia Category: Biotechnology Research Services Industry City: 77183,Croissy-Beaubourg,Ile-De-France Country: France Profile: Prestizia is located in …See details»
Société PRESTIZIA : Chiffre d'affaires, statuts, extrait d ... - Pappers
Jan 24, 2020 PRESTIZIA à CROISSY-BEAUBOURG (77183) : Bilans, statuts, chiffre d'affaires, dirigeants, actionnaires, levées de fonds, annonces légales, APE, NAF, TVA, RCS, SIREN ...See details»
Prestizia - Products, Competitors, Financials, Employees, …
Il constituait une étape supplémentaire des développements de Prestizia dans le cancer du rectum et devait permettre de renforcer le travail déjà accompli dans ce domaine. Le …See details»
19/12/2017 : THERADIAG provides an update on Prestizia and its ...
Dec 19, 2017 Croissy-Beaubourg and Montpellier, December 19, 2017, 6:00pm CET – THERADIAG (ISIN: FR0004197747, Ticker: ALTER, eligible for PEA-PME equity savings …See details»
Theradiag acquires Prestizia and its MicroRNA technology platform
Jun 28, 2012 Since its inception, Prestizia has collaborated with the University of Montpellier 2 and the CNRS. This article is accessible to registered users, to continue reading please …See details»
Prestizia SASU:Company Profile & Technical Research,Competitor …
Sep 27, 2023 Prestizia SASU is a company that provides Tropism, microRNA, Viral disease and more. Prestizia SASU is headquartered in France . Prestizia SASU was founded in 2011. …See details»
Theradiag acquiert Prestizia et sa plateforme technologique …
Jun 27, 2012 Theradiag, société basée à Marne-la-Vallée et spécialisée dans le théranostic et le diagnostic in vitro, en particulier dans le domaine des maladies auto-immunes, annonce …See details»
THERADIAG fait un point sur Prestizia et son partenariat avec HOB ...
Dec 19, 2017 Prestizia, filiale à 100% de Theradiag travaille sur des projets de recherche s’apparentant à de la recherche fondamentale dont l’objectif est de développer de nouveaux …See details»
France's Theradiag Buys microRNA Diagnostics Shop Prestizia
Jun 28, 2012 French diagnostics and theranostics firm Theradiag this week announced that it has acquired Prestizia, a five-employee subsidiary of privately held French investment firm …See details»
Theradiag Acquires miRNA Firm Prestizia | GenomeWeb
Jun 27, 2012 NEW YORK (GenomeWeb News) – French theranostics and in vitro diagnostics company Theradiag announced today it is acquiring biotech firm Prestizia for an undisclosed …See details»
Theradiag Acquires Prestizia and its Highly Innovative microRNA ...
Jun 29, 2012 Theradiag is already working with microRNA platform to develop new theranostic tests.See details»
Theradiag Expanding microRNA Assay Plans with HIV, Anti …
After buying small microRNA firm Prestizia last June, France's Theradiag is moving forward in development of several miRNA tests in the HIV disease area, as well as two companion …See details»
06/04/2016 : Launch of a new fully automated diagnostics system
Apr 6, 2016 Acceleration in the development of Theradiag’s In Vitro Diagnostics Business Unit with the development of the BioCLIA® 1 200. Croissy-Beaubourg and Montpellier, April 6, …See details»
Prestiza AG, Urnäsch - business-monitor.ch
Prestiza AG, entreprise active dans "Activités des marchands de biens immobiliers" - Registre du commerce, réseau, activités, décideurs et contacts, FOSCSee details»
Prestigia.com, spécialiste de la réservation d'hôtels de charme et …
2 days ago Créée en 2005 par Thami Tazi, entrepreneur, Meryem Tazi, traqueuse d’hôtels à travers le monde et Younes Chraibi, expert en nouvelles technologies, Prestigia . com, site de …See details»
Prestigia Immobilier, Leader de la promotion immobilière, se …
Prestigia Immobilier, Leader de la promotion immobilière, se positionne comme un acteur majeur sur le marché du logement neuf en France, notamment sur les villes du Grand Paris, Metz, …See details»